For patients whose insurance wont cover GLP-1 medications, lower-cost compounded versions can seem like an attractive alternative, but the researchers urge caution
To counter such impacts, some companies are exploring ways that GLP-1RA drugs could complement their existing solutions
When used as part of a supervised wellness program, GLP-1 therapies work by interacting with receptors in the brain, pancreas, and digestive system
While injection site discomfort is typically minimal and transient, GLP-1 receptor agonists are associated with several systemic side effects that patients should understand
Akt is the principal mediator of IGF-1s pro-survival, anti-apoptotic, and anabolic effects: it phosphorylates and inhibits pro-apoptotic factors, activates the mechanistic target of rapamycin complex 1 (mTORC1) to drive protein synthesis, and suppresses the FOXO transcription factors that promote muscle atrophy and proteolysis
Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials
